Clinical Trial Update: Capecitabine Plus Radiotherapy for Local Relapse Breast Cancer With Negative Her2 Tumours [Phase 2]

View source ↗

Summary

A Phase 2 trial of capecitabine plus radiotherapy for locally relapsed HER2-negative breast cancer. The study status is terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Capecitabine (capecitabine)

Snippet

Sponsor: Spanish Breast Cancer Research Group | Conditions: Breast Cancer | Phase 2 | Status: TERMINATED